Litcius/Paper detail

Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease

Nada Radwan, E. Khan, Mustafa T. Ardah, Tohru Kitada, M. Emdadul Haque

2023Nutrients10 citationsDOIOpen Access PDF

Abstract

Parkinson's disease (PD) is the second most common neurological disorder, pathologically characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) as well as the formation of Lewy bodies composed mainly of α-synuclein (α-syn) aggregates. It has been documented that abnormal aggregation of α-syn is one of the major causes of developing PD. In the current study, administration of ellagic acid (EA), a polyphenolic compound (10 mg/kg bodyweight), significantly decreased α-syn spreading and preserved dopaminergic neurons in a male C57BL/6 mouse model of PD. Moreover, EA altered the autophagic flux, suggesting the involvement of a restorative mechanism meditated by EA treatment. Our data support that EA could play a major role in the clearing of toxic α-syn from spreading, in addition to the canonical antioxidative role, and thus preventing dopaminergic neuronal death.

Topics & Concepts

Substantia nigraPars compactaDopaminergicParkinson's diseaseAutophagyEllagic acidPharmacologyNeurotoxicityChemistryVentral tegmental areaToxicityAlpha-synucleinDopamineMedicineNeuroscienceEndocrinologyInternal medicineBiologyDiseaseAntioxidantPolyphenolBiochemistryApoptosisParkinson's Disease Mechanisms and TreatmentsNanocomposite Films for Food PackagingPomegranate: compositions and health benefits
Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease | Litcius